Cavinton - Loaded Solid Lipid Nanoparticles: Design and Characterization

被引:0
作者
Mhetre, Raksha Laxman [1 ,2 ,3 ]
Hol, Vishal Bhanudas [2 ,3 ]
Bajaj, Amrita Narayan [1 ]
Jadhav, Ram [3 ]
机构
[1] CU Shah Coll Pharm, Dept Pharmaceut, Mumbai, Maharashtra, India
[2] JJT Univ Jhunjhunu, Chudella, Rajasthan, India
[3] RJSPMs Coll Pharm, Pune 412105, Maharashtra, India
来源
INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND PHYTOPHARMACOLOGICAL RESEARCH | 2013年 / 3卷 / 02期
关键词
Solid Lipid Nanoparticles; Cavinton; High shear homogenization (HSH);
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Solid lipid nanoparticles (SLNs) are novel colloidal particles for oral delivery with enhanced absorption rate. They overcome the disadvantages of other colloidal carriers such as emulsion, liposome, and polymeric nanoparticles. Cavinton is unique memory enhancer drug with short half-life and variable oral bioavailability (660%). In market, Cavinton is available as 5mg tablet thrice a day. The aim of the study was to develop controlled release SLNs by incorporating this drug in to lipid nanocarriers where nanosize particles and lipid used for formulation would help to control drug release over prolonged period. SLNs were prepared by High shear homogenization (HSH) technique using stearic acid as solid lipid core, Tween 80 and Poloxamer 188 as stabilizers. Formulations were optimized by 32 factorial design approach. Particle size and it's distribution were determined by Malvern Mastersizer and found to be 400 nm with polydispersity index 0.28. Transmission Electron Microscopy (TEM) shown that SLNs were uniform spherical in shape. In vitro release studies shown that SLNs dispersions were able to control the drug release and it followed diffusion controlled release mechanism. The palatability of nanodispersion was improved using sweetener and flavors. HSH was found to be effective method to prepare high quality SLNs for once day oral administration of Cavinton.
引用
收藏
页码:144 / 147
页数:4
相关论文
共 8 条
[1]  
BENCSATH P, 1976, ARZNEIMITTEL-FORSCH, V26, P1920
[2]   Solid lipid namoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs [J].
Hu, LD ;
Tang, X ;
Cui, FD .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (12) :1527-1535
[3]   Preparation and crystal modification of ibuprofen-loaded solid lipid microparticles [J].
Long Chunxia ;
Zhang Lijuan ;
Qian Yu .
CHINESE JOURNAL OF CHEMICAL ENGINEERING, 2006, 14 (04) :518-525
[4]   Solid lipid nanoparticles -: Production, characterization and applications [J].
Mehnert, W ;
Mäder, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (2-3) :165-196
[5]  
Muller R. H., 1998, PHARMAZEUTISCHE TECH
[6]   Solid lipid nanoparticles (SLN) for controlled drug delivery -: a review of the state of the art [J].
Müller, RH ;
Mäder, K ;
Gohla, S .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) :161-177
[7]  
Saffie-Sieverb R, 2005, DRUG DISCOV WORLD, P71
[8]   Solid lipid nanoparticles (SLN) for controlled drug delivery - Drug release and release mechanism [J].
zur Muhlen, A ;
Schwarz, C ;
Mehnert, W .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 45 (02) :149-155